ArticleBMC pregnancy and childbirth2026
Evaluation of the role of post-partum ultrasound of cesarean delivery scar on subsequent pregnancy outcomes: a preliminary study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study was to evaluate the association between postpartum ultrasound assessment of the cesarean scar and obstetric outcomes in subsequent pregnancies.
methodsWe conducted a retrospective cohort study at a tertiary referral center between 2020 and 2022. Women who underwent postpartum transvaginal ultrasound assessment of the cesarean scar were compared with a historical reference group (2017-2019) with a previous cesarean delivery who did not undergo scar evaluation between pregnancies. Cesarean scar defects (CSD) were defined according to Delphi consensus criteria. Maternal and neonatal outcomes, including placenta accreta spectrum (PAS), uterine rupture, dehiscence and preterm birth, were compared between groups.
resultsDuring the study period, 481 women underwent postpartum ultrasound assessment of the cesarean scar. Of these, 141 women subsequently conceived and delivered at our institution and were included in the study group. These patients were compared with 393 women in a historical reference group. Among the 105 patients with complete ultrasound assessment according to the Delphi criteria, 30 (28.6%) were diagnosed with a cesarean scar defect, while 75 (71.4%) had no detectable defect. Patients in the study group were significantly older (p = 0.02) and had significantly (p < 0.001) higher gravidity and parity than those in the reference group. The study group delivered at a significantly (p < 0.001) earlier gestational age. Major obstetric complications, including placenta accreta spectrum (PAS), uterine rupture, or dehiscence, were significantly more common in the study group than in the reference group (8/131 (5.8%) vs. 7/393 (1.7%); p = 0.029). The rate of preterm birth was also significantly higher in the study group compared to the reference group (16/138 (11.5%) vs. 20/393 (4.8%); p = 0.009).
conclusionImplementation of a post-partum ultrasound follow-up program for patients delivered by cesarean section enables standardized identification of cesarean scar defects before a subsequent pregnancy. In this cohort, women with a cesarean scar defect had higher rates of obstetric complications in subsequent pregnancies than women without a detectable defect. Standardized postpartum ultrasound evaluation may support risk stratification in future pregnancies. However, the study was not designed to evaluate the impact of ultrasound findings on clinical management, and the findings should be interpreted as exploratory associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.